Coagulopatia do trauma em pacientes pediátricos: uma abordagem baseada em evidências
Trauma-induced coagulopathy in pediatric patients: an evidence-based approach
Leila Costa Volpon; Raíssa Correia Rafael; Ana Paula de Carvalho Panzeri Carlotti
Resumo
Palavras-chave
Abstract
Keywords
Referências
1 de Almeida CK, Krauzer CC, Sela E de O, Cichowicz T de F, da Silveira A, Soccol LS. et al. Principais causas de morte em crianças e adolescentes no Brasil: análise de 2011 a 2020. Rev. Contexto & Saúde. 2024;24(49):e14647. doi: 10.21527/2176-7114.2024.49.14647.
2 Maw G, Furyk C. Pediatric Massive Transfusion: A Systematic Review. Pediatr Emerg Care. 2018;34(8):594-598. doi: 10.1097/PEC.0000000000001570..
3 Parmar N, Albisetti M, Berry LR, Chan AK. The fibrinolytic system in newborns and children. Clin Lab. 2006;52(3-4):115-24. Erratum in: Clin Lab. 2006;52(5-6):324.
4 Nair A, Flori H, Cohen MJ. Characterization of organ dysfunction and mortality in pediatric patients with trauma with acute traumatic coagulopathy. Trauma Surg Acute Care Open. 2020;5(1):e000382. doi: 10.1136/tsaco-2019-000382.
5 Spinella PC, Leonard JC, Gaines BA, et al. Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study. Crit Care Med. 2022;50(4):e382-e392. doi:10.1097/CCM.0000000000005383.
6 Christiaans SC, Duhachek-Stapelman AL, Russell RT, Lisco SJ, Kerby JD, Pittet JF. Coagulopathy after severe pediatric trauma. Shock. 2014;41(6):476-90. doi:10.1097/SHK.000000000000015.
7 Hendrickson JE, Shaz BH, Pereira G, et al. Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr. 2012;160(2):204-9.e3. doi:10.1016/j.jpeds.2011.08.019.
8 Strumwasser A, Speer AL, Inaba K, Branco BC, Upperman JS, Ford HR, Lam L, Talving P, Shulman I, Demetriades D. The impact of acute coagulopathy on mortality in pediatric trauma patients. J Trauma Acute Care Surg. 2016;81(2):312-8. doi: 10.1097/TA.0000000000001060.
9 Leeper CM, Neal MD, McKenna CJ, Gaines BA. Trending Fibrinolytic Dysregulation: Fibrinolysis Shutdown in the Days After Injury Is Associated With Poor Outcome in Severely Injured Children. Ann Surg. 2017;266(3):508-515. doi: 10.1097/SLA.0000000000002355.
10 Borgman MA, Nishijima DK. Tranexamic acid in pediatric hemorrhagic trauma. J Trauma Acute Care Surg. 2023;94(1S Suppl 1):S36-S40. doi: 10.1097/TA.0000000000003775.
11 Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100. doi: 10.1186/s13054-016-1265-x.
12 Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: 10.1186/s13643-016-0384-4.
13 Howik J et al. Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009). Disponível em:
14 Burggraf M, Polan C, Husen M, et al. Trauma induced clotting factor depletion in severely injured children: a single center observational study. World J Emerg Surg. 2020;15(1):31. doi:10.1186/s13017-020-00311-6.
15 Davenport R, Manson J, De'Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med. 2011;39(12):2652-8. doi:10.1097/CCM.0b013e3182281af5.
16 Leeper CM, Kutcher M, Nasr I, et al. Acute traumatic coagulopathy in a critically injured pediatric population: Definition, trend over time, and outcomes. J Trauma Acute Care Surg. 2016;81(1):34-41. doi:10.1097/TA.0000000000001002.
17 Gaessler H, Helm M, Kulla M, et al. Prehospital evaluation and detection of induced coagulopathy in trauma: The PREDICT study. J Trauma Acute Care Surg. 2021;91(2):344-51. doi:10.1097/TA.0000000000003246.
18 Ostrowski SR, Henriksen HH, Stensballe J, Gybel-Brask M, Cardenas JC, Baer LA, et al. Sympathoadrenal activation and endotheliopathy are drivers of hypocoagulability and hyperfibrinolysis in trauma: A prospective observational study of 404 severely injured patients. J Trauma Acute Care Surg. 2017;82(2):293-301. doi: 10.1097/TA.0000000000001304.
19 Coggins AR, Nguyen VDD, Pasalic L, Ramesh M, Wangoo K. Utility of point of care viscoelastic haemostatic assays for trauma patients in the emergency department. Scand J Trauma Resusc Emerg Med. 2025;33(1):68. doi:10.1186/s13049-025-01388-1.
20 Lindsay C, Davenport R, Baksaas-Aasen K, et al. Correction of Trauma-induced Coagulopathy by Goal-directed Therapy: A Secondary Analysis of the ITACTIC Trial. Anesthesiology. 2024;141(5):904-12. doi:10.1097/ALN.0000000000005183.
21 Vogel AM, Radwan ZA, Cox CS Jr, Cotton BA. Admission rapid thrombelastography delivers real-time "actionable" data in pediatric trauma. J Pediatr Surg. 2013;48(6):1371-6. doi:10.1016/j.jpedsurg.2013.03.036.
22 Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016;2016(8):CD007871. doi: 10.1002/14651858.CD007871.pub3.
23 George S, Wake E, Sweeny A, Campbell D, Winearls J. Rotational thromboelastometry in children presenting to an Australian major trauma centre: A retrospective cohort study. Emerg Med Australas. 2022 Aug;34(4):590-8. doi: 10.1111/1742-6723.13939.
24 Stensballe J, Henriksen HH, Johansson PI. Early haemorrhage control and management of trauma-induced coagulopathy: the importance of goal-directed therapy. Curr Opin Crit Care. 2017;23(6):503-10. doi:10.1097/MCC.0000000000000466.
25 Schauer SG, April MD, Becker TE, Cap AP, Borgman MA. High crystalloid volumes negate benefit of hemostatic resuscitation in pediatric wartime trauma casualties. J Trauma Acute Care Surg. 2020 Aug;89(2S Suppl 2):S185-S191. doi: 10.1097/TA.0000000000002590. PMID: 31972756.
26 Polites SF, Nygaard RM, Reddy PN, et al. Multicenter study of crystalloid boluses and transfusion in pediatric trauma - When to go to blood?. J Trauma Acute Care Surg. 2018;85(1):108-12. doi:10.1097/TA.0000000000001897.
27 Polites SF, Moody S, Williams RF, et al. Timing and volume of crystalloid and blood products in pediatric trauma: An Eastern Association for the Surgery of Trauma multicenter prospective observational study. J Trauma Acute Care Surg. 2020;89(1):36-42. doi:10.1097/TA.0000000000002702.
28 Zhu H, Chen B, Guo C. Aggressive crystalloid adversely affects outcomes in a pediatric trauma population. Eur J Trauma Emerg Surg. 2021;47(1):85-92. doi:10.1007/s00068-019-01134-0.
29 Edwards MJ, Lustik MB, Clark ME, Creamer KM, Tuggle D. The effects of balanced blood component resuscitation and crystalloid administration in pediatric trauma patients requiring transfusion in Afghanistan and Iraq 2002 to 2012. J Trauma Acute Care Surg. 2015;78(2):330-5. doi: 10.1097/TA.0000000000000469.
30 Shirek G, Phillips R, Shahi N, et al. To give or not to give? Blood for pediatric trauma patients prior to pediatric trauma center arrival. Pediatr Surg Int. 2022;38(2):285-93. doi:10.1007/s00383-021-05015-9.
31 Morgan KM, Abou-Khalil E, Strotmeyer S, Richardson WM, Gaines BA, Leeper CM. Association of Prehospital Transfusion With Mortality in Pediatric Trauma. JAMA Pediatr. 2023;177(7):693-9. doi:10.1001/jamapediatrics.2023.1291.
32 Valentine SL, Bembea MM, Muszynski JA, et al. Consensus Recommendations for RBC Transfusion Practice in Critically Ill Children From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med. 2018;19(9):884-98. doi:10.1097/PCC.0000000000001613.
33 Nellis ME, Karam O, Valentine SL, et al. Executive Summary of Recommendations and Expert Consensus for Plasma and Platelet Transfusion Practice in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB). Pediatr Crit Care Med. 2022;23(1):34-51. doi:10.1097/PCC.0000000000002851.
34 Leeper CM, Neal MD, Billiar TR, Sperry JL, Gaines BA. Overresuscitation with plasma is associated with sustained fibrinolysis shutdown and death in pediatric traumatic brain injury. J Trauma Acute Care Surg. 2018;85(1):12-7. doi:10.1097/TA.0000000000001836.
35 Burt T, Guilliam A, Cole E, Davenport R. Effect of early administration of fibrinogen replacement therapy in traumatic haemorrhage: a systematic review and meta-analysis of randomised controlled trials with narrative synthesis of observational studies. Crit Care. 2025;29(1):49. doi:10.1186/s13054-025-05269-y.
36 Hannadjas I, James A, Davenport R, Lindsay C, Brohi K, Cole E. Prothrombin complex concentrate (PCC) for treatment of trauma-induced coagulopathy: systematic review and meta-analyses. Crit Care. 2023;27(1):422. doi:10.1186/s13054-023-04688-z.
37 Itagaki Y, Hayakawa M, Takahashi Y, et al. The efficacy of coagulation factor concentrates in the management of patients with trauma-induced coagulopathy: a systematic review and meta-analysis. Shock. 2025;63(5):695-705. doi:10.1097/SHK.0000000000002534.
38 Morgan KM, Gaines BA, Richardson WM, Strotmeyer S, Leeper CM. Recognizing life-threatening bleeding in pediatric trauma: A standard for when to activate massive transfusion protocol. J Trauma Acute Care Surg. 2023;94(1):101-6. doi:10.1097/TA.0000000000003784.
39 Meizoso JP, Moore EE, Pieracci FM, et al. Role of Fibrinogen in Trauma-Induced Coagulopathy. J Am Coll Surg. 2022;234(4):465-73. doi:10.1097/XCS.0000000000000078.
40 Samuels JM, Moore EE, Silliman CC, et al. Severe traumatic brain injury is associated with a unique coagulopathy phenotype. J Trauma Acute Care Surg. 2019;86(4):686-93. doi:10.1097/TA.0000000000002173.
41 Leeper CM, Strotmeyer SJ, Neal MD, Gaines BA. Window of Opportunity to Mitigate Trauma-induced Coagulopathy: Fibrinolysis Shutdown not Prevalent Until 1 Hour Post-injury. Ann Surg. 2019;270(3):528-34. doi:10.1097/SLA.0000000000003464.
42 Hesling JD, Paulson MW, McKay JT, et al. Characterizing pediatric supermassive transfusion and the contributing injury patterns in the combat environment. Am J Emerg Med. 2022;51:139-43. doi:10.1016/j.ajem.2021.10.032.
43 Zhu CS, Braverman M, Goddard S, et al. Prehospital shock index and systolic blood pressure are highly specific for pediatric massive transfusion. J Trauma Acute Care Surg. 2021;91(4):579-83. doi:10.1097/TA.0000000000003275.
44 Spinella PC, Leonard JC, Marshall C, et al. Transfusion Ratios and Deficits in Injured Children With Life-Threatening Bleeding. Pediatr Crit Care Med. 2022;23(4):235-44. doi:10.1097/PCC.0000000000002907.
45 Butler EK, Mills BM, Arbabi S, et al. Association of Blood Component Ratios With 24-Hour Mortality in Injured Children Receiving Massive Transfusion. Crit Care Med. 2019;47(7):975-83. doi:10.1097/CCM.0000000000003708.
46 Mehl SC, Vogel AM, Glasgow AE, et al. Prevalence and outcomes of high versus low ratio plasma to red blood cell resuscitation in a multi-institutional cohort of severely injured children. J Trauma Acute Care Surg. 2024;97(3):452-9. doi:10.1097/TA.0000000000004301.
47 Noland DK, Apelt N, Greenwell C, Tweed J, Notrica DM, Garcia NM, et al. Massive transfusion in pediatric trauma: An ATOMAC perspective. J Pediatr Surg. 2019;54(2):345-9. doi: 10.1016/j.jpedsurg.2018.10.040.
48 Akl M, Anand T, Reina R, El-Qawaqzeh K, Ditillo M, Hosseinpour H, et al. Balanced hemostatic resuscitation for bleeding pediatric trauma patients: A nationwide quantitative analysis of outcomes. J Pediatr Surg. 2022;57(12):986-993. doi: 10.1016/j.jpedsurg.2022.07.005.
49 Cunningham ME, Rosenfeld EH, Zhu H, Naik-Mathuria BJ, Russell RT, Vogel AM. A High Ratio of Plasma: RBC Improves Survival in Massively Transfused Injured Children. J Surg Res. 2019;233:213-220. doi: 10.1016/j.jss.2018.08.007.
50 ACS TQIP Massive Transfusion In Trauma Guidelines. Available at:
51 Hutspardol S, Borja T, Kroeker J, et al. Comparison of conventional coagulation tests and ROTEM in identifying trauma-induced coagulopathy for massive haemorrhage protocol activation. Transfus Med. 2025;35(3):266-74. doi:10.1111/tme.13128.
52 Leeper CM, Yazer MH, Cladis FP, Saladino R, Triulzi DJ, Gaines BA. Use of Uncrossmatched Cold-Stored Whole Blood in Injured Children With Hemorrhagic Shock. JAMA Pediatr. 2018;172(5):491-2. doi:10.1001/jamapediatrics.2017.5238.
53 Leeper CM, Yazer MH, Neal MD. Whole-Blood Resuscitation of Injured Patients: Innovating from the Past. JAMA Surg. 2020;155(8):771-2. doi:10.1001/jamasurg.2020.0811.
54 Anand T, Obaid O, Nelson A, et al. Whole blood hemostatic resuscitation in pediatric trauma: A nationwide propensity-matched analysis. J Trauma Acute Care Surg. 2021;91(4):573-8. doi:10.1097/TA.0000000000003306.
55 Gaines BA, Yazer MH, Triulzi DJ, et al. Low Titer Group O Whole Blood In Injured Children Requiring Massive Transfusion. Ann Surg. 2023;277(4):e919-e924. doi:10.1097/SLA.0000000000005251.
56 Maeda T, Michihata N, Sasabuchi Y, et al. Safety of Tranexamic Acid During Pediatric Trauma: A Nationwide Database Study. Pediatr Crit Care Med. 2018;19(12):e637-e642. doi:10.1097/PCC.0000000000001724.
57 Mahajerin A, Petty JK, Hanson SJ, Thompson AJ, O'Brien SH, Streck CJ, et al. Prophylaxis against venous thromboembolism in pediatric trauma: A practice management guideline from the Eastern Association for the Surgery of Trauma and the Pediatric Trauma Society. J Trauma Acute Care Surg. 2017;82(3):627-636. doi: 10.1097/TA.0000000000001359.
58 Yen J, Van Arendonk KJ, Streiff MB, et al. Risk Factors for Venous Thromboembolism in Pediatric Trauma Patients and Validation of a Novel Scoring System: The Risk of Clots in Kids With Trauma Score. Pediatr Crit Care Med. 2016;17(5):391-9. doi:10.1097/PCC.0000000000000699.
59 Leeper CM, Neal MD, McKenna C, Sperry JL, Gaines BA. Abnormalities in fibrinolysis at the time of admission are associated with deep vein thrombosis, mortality, and disability in a pediatric trauma population. J Trauma Acute Care Surg. 2017;82(1):27-34. doi:10.1097/TA.0000000000001308.
60 Mahajerin A, Petty JK, Hanson SJ, Shabanova V, Faustino EVS. Use of Pharmacologic Prophylaxis Against Venous Thromboembolism in Hospitalized Injured Children. J Pediatr Hematol Oncol. 2022;44(2):e349-e357. doi:10.1097/MPH.0000000000002167.
61 Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471-82. doi: 10.1001/jama.2015.12.
62 CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5.
63 Ribeiro Junior MAF, Pacheco LS, Duchesne JC, Parreira JG, Mohseni S. Damage control resuscitation: how it's done and where we can improve. A view of the Brazilian reality according to trauma professionals. Rev Col Bras Cir. 2025;51:e20243785. doi: 10.1590/0100-6991e-20243785-en.
64 Moore EE, Moore HB, Kornblith LZ, et al. Trauma-induced coagulopathy. Nat Rev Dis Primers. 2021;7(1):30. doi:10.1038/s41572-021-00264-3.
65 Yang WT, Wang IJ, Cho SJ, Yeom SR, Park SW, Tae WU, Goh TS, Huh U, Ryu D, Song C, Cho YM. Roles of lactate and base deficit in predicting traumatic coagulopathy. PLoS One. 2025 Jul 11;20(7):e0327321. doi: 10.1371/journal.pone.0327321. PMID: 40644352; PMCID: PMC12250580.
66 Cotton BA, Guy JS, Morris JA Jr, Abumrad NN. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock. 2006;26(2):115-21. doi:10.1097/01.shk.0000209564.84822.f2.
67 Reppucci ML, Pickett K, Stevens J, Nolan MM, Moulton SL. Outcomes in Pediatric Trauma Patients Who Receive Blood Transfusion. J Surg Res. 2023;282:232-8. doi:10.1016/j.jss.2022.10.007.
68 Tama MA, Stone ME Jr, Blumberg SM, Reddy SH, Conway EE Jr, Meltzer JA. Association of Cryoprecipitate Use With Survival After Major Trauma in Children Receiving Massive Transfusion. JAMA Surg. 2021;156(5):453-60. doi:10.1001/jamasurg.2020.7199.
69 Horst J, Leonard JC, Vogel A, Jacobs R, Spinella PC. A survey of US and Canadian hospitals' paediatric massive transfusion protocol policies. Transfus Med. 2016;26(1):49-56. doi:10.1111/tme.12277.
70 Frelich M, Bebej M, Pavlícek J, et al. HMGB-1 as a predictor of major bleeding requiring activation of a massive transfusion protocol in severe trauma. Sci Rep. 2025;15(1):4651. doi:10.1038/s41598-025-89139-1.
71 Johansson PI, Vigstedt M, Curry NS, et al. Trauma induced coagulopathy is limited to only one out of four shock induced endotheliopathy (SHINE) phenotypes among moderate-severely injured trauma patients: an exploratory analysis. Scand J Trauma Resusc Emerg Med. 2024;32(1):71. doi:10.1186/s13049-024-01236-8.
72 Kamyszek RW, Leraas HJ, Reed C, Ray CM, Nag UP, Poisson JL, Tracy ET. Massive transfusion in the pediatric population: A systematic review and summary of best-evidence practice strategies. J Trauma Acute Care Surg. 2019;86(4):744-54. doi: 10.1097/TA.0000000000002188.
73 Yazer MH, Jackson B, Sperry JL, Alarcon L, Triulzi DJ, Murdock AD. Initial safety and feasibility of cold-stored uncrossmatched whole blood transfusion in civilian trauma patients. J Trauma Acute Care Surg. 2016;81(1):21-6. doi: 10.1097/TA.0000000000001100.
74 Kornelsen E, Kuppermann N, Nishijima DK, et al. Effectiveness and safety of tranexamic acid in pediatric trauma: A systematic review and meta-analysis. Am J Emerg Med. 2022;55:103-10. doi:10.1016/j.ajem.2022.01.069.
75 Nishijima DK, VanBuren JM, Linakis SW, et al. Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): A pilot randomized trial. Acad Emerg Med. 2022;29(7):862-73. doi:10.1111/acem.14481.
Submetido em:
16/12/2025
Aceito em:
02/02/2026
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email